vTv Therapeutics Inc buy melinda
Start price
31.10.18
/
50%
€2.23
Target price
17.12.18
€3.61
Performance (%)
-34.82%
End price
17.12.18
€1.45
Summary
This prediction ended on 17.12.18 with a price of €1.45. Massive losses of -34.82% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
vTv Therapeutics Inc | - | - | - | - |
iShares Core DAX® | 0.000% | -2.064% | 13.111% | 16.685% |
iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% | 43.441% |
iShares Nikkei 225® | 1.568% | -5.892% | 19.592% | 4.617% |
iShares S&P 500 | 0.334% | -2.281% | 27.745% | 41.046% |
Comments by melinda for this prediction
In the thread vTv Therapeutics Inc diskutieren
SecteurRecherche biotechnologique et médicale
Operates as a clinical-stage pharmaceutical holding company, which focuses on the discovery and development of human therapeutics
vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical holding company.
The firm engages in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs.
Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer.
The company was founded on April 2, 2015 and is headquartered in High Point, NC.
vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical holding company.
The firm engages in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs.
Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer.
The company was founded on April 2, 2015 and is headquartered in High Point, NC.
Nombre d'employés : 56 personnes.
(Vom Mitglied beendet)
Stopped prediction by melinda for vTv Therapeutics Inc
vTv Therapeutics Inc
Start price
Target price
Perf. (%)
€1.59
29.03.19
29.03.19
€2.26
04.11.21
04.11.21
-23.56%
05.11.21
05.11.21
vTv Therapeutics Inc
Start price
Target price
Perf. (%)
€4.27
03.10.18
03.10.18
€3.79
03.10.18
03.10.18
0.21%
03.10.18
03.10.18
vTv Therapeutics Inc
Start price
Target price
Perf. (%)
€1.76
02.10.18
02.10.18
€2.35
03.10.18
03.10.18
77.60%
03.10.18
03.10.18
vTv Therapeutics Inc
Start price
Target price
Perf. (%)
€6.01
18.02.18
18.02.18
€6.77
20.08.18
20.08.18
-85.02%
20.08.18
20.08.18
vTv Therapeutics Inc
Start price
Target price
Perf. (%)
€4.00
06.12.17
06.12.17
€6.31
03.01.18
03.01.18
40.12%
03.01.18
03.01.18
vTv Therapeutics Inc
Start price
Target price
Perf. (%)
€5.00
25.04.17
25.04.17
€5.41
18.09.17
18.09.17
8.30%
18.09.17
18.09.17